| « Previous month | Next month » |
Drug development services provider Aptuit has announced it is about to invest $100m to expand its operations, just a few weeks after completing two major acquisitions.
A technology designed to preserve living cells for longer could significantly reduce the number of animals used in medical research, according to its creators Abcellute.
Adept Technology has introduced a ceiling-mounted version of its s800 series Cobra robot. The inverted robot offers high-speed packaging and assembly with a wider reach, while leaving a much clearer working area.
A host of budding drug discovery firms were bestowed with recognition for their performances during a recently-held 2006 Frost & Sullivan European Healthcare awards ceremony.
German firm Sartorius has merged its biotech unit with biopharmaceutical supplier Stedim Biosystems, forming a company anticipated to generate sales of €400-420m during 2007.
A new biosensor developed by AlphaSniffer can detect viruses, bacteria, proteins, nucleic acids and aptamers in minutes leading to faster and more efficient analyses, according to the US company.
Scientists have used a biochemical chip to explain the important role a certain protein plays in the mating habits of yeast cells. The finding could lead to new cancer drugs with fewer side effects.
A milestone in the fight against both human and bird flu could help scientists develop new vaccines and therapies against the virus, preparing the world in case of a pandemic.
A new process engineering service aims to improve workflow efficiency by using advanced models to identify and eliminate laboratory bottlenecks and plan for future changes.
A round up of recent product releases from across the industry.
Johnson Matthey's metal scavenging system, Smopex, is designed to remove precious metals at high speed from solutions and active pharmaceutical ingredients (APIs).
Pharmaceutical services group Almac Sciences has teamed up with enzyme catalyst firm BioCatalytics on process development and manufacture of chiral intermediates and active pharmaceutical ingredients (APIs).
Preclinical and early-phase drug discovery will be the next service area to take off in India, Dr. Reddy's CEO GV Prasa predicted at a conference yesterday.
Israeli-based Chemada has announced that heavy brines can be used as solvent in pharmaceutical applications to cut waste and costs. The company made the announcement at last week's InformexUSA show in San Francisco.
Northern Ireland-based Almac Services has recently been awarded a potent compound safety certification by SafeBridge, confirming that Almac is capable of handling potent compounds safely and is able to limit exposure using closed laboratory systems.
A round up of recent product releases from across the industry.
High demand of Syrris' batch and flow chemistry reactors has forced them to double their sales force to cope with demand.
The new 'whole' DNA microarray promises to lower the cost and increase the speed of drug discovery processes.
Materia's metathesis platform continues to excite the pharmaceutical industry as they follow their recent license to Merck with a license to Aileron Therapeutics.
Dutch chemicals and ingredients manufacturer DSM has posted record end of year results with €809m operating profit, up six per cent on 2005.
Charles River Laboratories has posted its fourth quarter results for 2006, painting a picture of sluggish profitability and sales.
UK contract research organisation (CRO) Geneservice has announced its acquisition of the DNA sequencing facility in the University of Oxford's Biochemistry Department.
The new Metabolomics system from ESA promises to speed up biomarker discovery and reduce the overwhelming amounts of data often associated with these studies.
The International Society for Pharmaceutical Engineering (ISPE) has released its latest industry guide, covering the commissioning and qualification of pharmaceutical water and steam systems.
Scientists have mapped the most important genes associated with the risk of developing Type II diabetes, bringing a genetic test to identify those most at risk a step closer.
Scientists have developed a microchip system that can sieve through biomolecules, such as proteins, in search of the tell-tale signs of disease.
Applied Biosystems are soon to launch their next generation genetic analysis platform into a market that should allow a whole new wave of biological understanding.
Bigger is not necessarily better in the UK's laboratory equipment market, with smaller firms often outperforming their larger rivals.
Recent rapid advances in nanotechnology have allowed scientists, for the first time, to film gold atoms sinking into a surface in real time.
A multinational team of researchers based in the UK has found a way to make carbon nanotubes easily cross biological barriers, opening up the potential for a new form of drug delivery.
Italy's Bonfiglioli Engineering has launched a leak testing machine for syringes, with the ability to check and remove syringes that are faulty before leaving the factory.
PerkinElmer will now offer a new lab equipment relocation service to support customers who need to move and require special care for their testing and manufacturing equipment.
AstraZeneca has continued to rapidly refocus and bolster its biologics pipeline through collaboration deals, this time with a deal for antibody producing technology.
Laureate Pharma will now offer extra bioprocessing services to its customers following a new partnership deal signed with Boehringer Ingelheim.
US-based start-up company Medipacs is developing a miniaturised digital pump, no bigger than a quarter, which could become the first patch-like product to help diabetics manage their insulin therapy.
A tool that predicts which experimental drugs will ultimately be approved for release could cut development costs by nearly 40 per cent, saving pharma companies hundreds of millions per new drug.
After acquisitions and new products to speed up drug discovery, winning an award was the icing on the cake for lab automation specialist Thermo Fisher.
The first next generation sequencer from Roche and 454 is already proving popular only weeks after its release.
A new 'lab-on-a-chip' electrophoresis separation device allows higher resolution separations and could enable faster diabetes immunoassay diagnoses.
MorphoSys has just opened new UK headquarters for its antibody-focused business unit, giving the company expanded capacity for its antibody production - a rapidly growing market in the UK.
| « Previous month | Next month » |